Firefly Neuroscience vs Scopio Labs
Firefly Neuroscience vs Scopio Labs, compared side by side on 24 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Firefly Neuroscience is on 56/100 and Scopio Labs on 61/100.
Where each one leads
Firefly Neuroscience
- agent readiness: 49/100 against 21/100
Scopio Labs
- our overall score: 61/100 against 56/100
- headcount: 163 against 25
- headcount growth: +9.8% against -3.3%
- funding raised: $125M against $45.4M
- LinkedIn following: 29,818 against 8,237
At a glance
| Measure | Firefly Neuroscience | Scopio Labs |
|---|---|---|
| What it is | Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology. | Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection. |
| Category | Healthcare, Neurology, Mental Health, Brain EEG Injury | Healthcare, Diagnostics, Computational Microscopes, Medical Imaging |
| Sells toBusiness model | B2B | B2B |
| Offering | Software, Hardware | Hardware, Software |
| Founded | 2006 | 2014 |
| Headquarters | San Francisco, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Firefly Neuroscience | Scopio Labs |
|---|---|---|
| Employees | 25 | 163 |
| Headcount growthLast 12 months | -3.3% | +9.8% |
| Total funding | $45.4M | $125M |
| Latest round | Series C | Series D |
| LinkedIn followers | 8,237 | 29,818 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Firefly Neuroscience | Scopio Labs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 61/100 |
| Traction | 52/100 | 60/100 |
| Team | 50/100 | 70/100 |
| Community | 8/100 | Not published |
| Search visibility | 25/100 | 34/100 |
| Quality | 62/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (49/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Firefly Neuroscience | Scopio Labs |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Tag Manager, Facebook Pixel |
| Support stack | HubSpot | Zendesk |
Firefly Neuroscience vs Scopio Labs: common questions
Which is better, Firefly Neuroscience or Scopio Labs?
On our 0-100 score Scopio Labs rates higher (61/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 24 data points above: read the rows that match what you are buying for.
How do Firefly Neuroscience and Scopio Labs compare on the numbers?
Firefly Neuroscience leads on agent readiness (49/100 against 21/100). Scopio Labs leads on our overall score (61/100 against 56/100), headcount (163 against 25), headcount growth (+9.8% against -3.3%), funding raised ($125M against $45.4M), LinkedIn following (29,818 against 8,237).
Read the full Firefly Neuroscience review and pricing or the Scopio Labs review and pricing. You can also browse other Firefly Neuroscience alternatives we track.